期刊文献+

IL-6对RAW264.7细胞成熟分化的体外实验研究 预览

Effect of interleukin-6 on the differentiation of RAW264.7 cells in vitro
在线阅读 下载PDF
分享 导出
摘要 目的探讨研究白介素-6(Interleukin-6,IL-6)对核因子NF-κB受体活化因子配体(Receptor activator of nuclear kappa Bligand,RANKL)及对破骨前体细胞的成熟分化和溶骨效应。方法破骨前体细胞RAW264.7细胞经50ng/mLRANKL诱导1d后将其分为:1、空白对照组(RANKL+PBS)2、低浓度IL-6组(RANKL+50ng/mLIL-6)3、中浓度IL-6组(RANKL+100ng/mLIL-6)4、高浓度IL-6组(RANKL+150ng/mLIL-6)。连续培养9d后,进行HE染色检测成熟破骨细胞生成量;通过抗酒石酸酸性磷酸酶(Tartrate resistant acid phosphatase,TRAP)染色法观察TRAP阳性多核细胞的情况;运用扫描电镜检测破骨细胞在骨片上的骨吸收陷窝形成情况。结果HE染色中,成熟破骨细胞生成量中、高浓度IL-6组明显少于低浓度IL-6组(P<0.05),低浓度IL-6组和空白对照组间无明显差别(P >0.05)。②通过TRAP染色后,经染色阳性区域面积与视野面积的百分比计算,中、高浓度IL-6组与明显少于低浓度和空白对照组(P<0.05)。③扫描电镜观察发现骨吸收陷窝面积与视野面积的百分比随着IL-6浓度的增高,相比空白对照组有显著减少,且高浓度IL-6组中陷窝形成最少(P<0.05)。结论IL-6能直接作用于经RANKL诱导的RAW264.7细胞,能明显抑制破骨细胞激活分化,并降低破骨细胞所致的骨吸收效应。当IL-6浓度超过50ng/mL时,其抑制破骨细胞的骨吸收效应更加明显。 Objective To investigate the effect of interleukin-6(IL-6),a prototypical cytokine featuring pleiotropic and redundant activity,on the osteoclastic differentiation of RANKL-stimulated RAW264.7 macrophages.Methods RAW264.7 cells were pre-treated with 50ng/mL RANKL for 1 day and followed by IL-6 treatment.Then they were incubated and divided into 4 groups:control group(50ng/mL RANKL+PBS),low(50ng/mL RANKL+50ng/mL IL-6),medium(50ng/mL RANKL+100ng/mL IL-6),and high concentration(50 ng/mL RANKL+150ng/mL IL-6)group for 9 consecutive days.These cells were harvested and stained with hematoxylin-eosin(HE)and tartrate-resistant acid phosphatase(TRAP).The resorption pits of bone slices were observed using scanning electron microscope(SEM).Results HE stains showed that there were increased mature osteoclast cells in the control compared to 100 and 150ng/mL of IL-6 treatment,with a difference being statistically significant(P<0.05).However,the difference did not reach statistical significance between the control and 50ng/mL IL-6 treatment(P >0.05).Similarly,compared to the control,TRAP-positive multinucleated osteoclasts(more than 3 nucleus)significantly decreased under the constant stimuli of 100 and 150ng/mL of IL-6 concentration(P<0.05).Under SEM observation,multiple bone resorption formation was clearly visualized in control group.In contrast,few formations of bone resorption and mature osteoclasts were found when the addition of IL-6 concentration was more than 50ng/mL(P<0.05).Conclusion IL-6 at 100 or 150ng/mL concentrations can powerfully suppress the differentiation of mature osteoclasts,thereby resulting in a remarkably reduction of osteolysis.
作者 王信 张怡 陈萍 季文军 马亚萍 敖俊 张军 WANG Xin;ZHANG Yi;CHEN Ping;JI Wenjun;MA Yaping;AO Jun;ZHANG Jun(Department of Orthopedic Surgery,Affiliated Hospital of Zunyi Medical University,Zunyi 563000,Guizhou;Department of Preventive Medicine,School of Public Health,Zunyi Medical University,Zunyi 563000 Guizhou;Joint Orthopedic Research Center of Zunyi Medical University & University of Rochester Medical Center,Zunyi MedicalUniversity,Zunyi 563000,China)
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2019年第1期62-66,共5页 Chinese Journal of Osteoporosis
基金 国家自然科学基金(31760266)。
关键词 破骨细胞 骨质疏松 RAW264.7细胞 RANKL IL-6 osteoclasts osteoporosis RAW264. 7 cells RANKL IL-6
作者简介 共同第一作者:王信;共同第一作者:张怡;通信作者:敖俊,Email:Ao00jun@163.com;通信作者:张军,Email:1013030639@qq.com.
  • 相关文献

参考文献3

二级参考文献57

  • 1李楠 ,林旭 ,王和鸣 ,郑良朴 ,林一萍 ,沈霖 ,周琳瑛 ,钟秀容 ,林芳 .IL-6影响骨髓基质细胞凋亡机理的初步探讨[J].中国骨质疏松杂志,2005,11(1):12-16. 被引量:6
  • 2屠冠军,安贵峰,马立学.核因子与白细胞介素-6在骨质疏松模型中的表达特征[J].中华实验外科杂志,2005,22(9):1091-1093. 被引量:1
  • 3Scheidt-Nave C, Bismar H, Leidig-Bruckner G, etal. Serum interleukin-6 is a major predictor of bone loss in woman specific to the first decade past menopause[J]. J Clin Endocrinol Metab, 2001, 86:2032-2042. 被引量:1
  • 4Manolagas SC. The role of IL-6 type cytokines and their receptors in bone[J]. Ann N Y Acad Sci, 1998, 840:194-204. 被引量:1
  • 5Quaedackers ME, Van Den Brink CE, Wissink S, et al. 4-hydroxy-tamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta[J]. Endocrinology, 2001, 142(3): 1156-1166. 被引量:1
  • 6Helen Brady, Mary Doubleday, Leah M, et al. Differential response of estrogen receptors a and β to SP500263, a novel potent selective estrogen receptor modulator[J]. Mol Pharmacol, 2002,8(3):562-568. 被引量:1
  • 7Ozmen B, Kirmaz C, Aydin K, et al. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-betal and bone turnover markers in the treatment of postmenopausal osteoporosis[J]. Eur Cytokine Netw, 2007, 18(3): 148-153. 被引量:1
  • 8Chae H J, Chae SW, Chin HY, et al. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts[J]. Bone, 2001, 28:45-53. 被引量:1
  • 9Jia C. Dai, Ping He, Xin Chen, et al. TNF-a and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics[J]. Bone, 2006, 38:509-520. 被引量:1
  • 10Franchimont N, Wertz S, Malaise M. Interleukin-6: an osteotropic factor influencing bone formation[J]. Bone, 2005, 37:601-606. 被引量:1

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈